Fundación Pública Andaluza para la gestión de la Investigación en Sevilla — CureCurrent

How to interpret these research links

Connected source records

The exact organization name Fundación Pública Andaluza para la gestión de la Investigación en Sevilla appears in 30 distinct published trial records. The links retain registry-reported sponsor and collaborator roles; differently spelled legal entities are not automatically merged. Recruiting status describes the current published registry snapshot, not an independently verified availability guarantee.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Published trials30

Recruiting shown2

Roles2

SourceClinicalTrials.gov

Clinical trials

30 shown

UNMASK: Unveiling the Pathobiology of Metabolic Dysfunction-Associated Steatotic Liver Disease for the Discovery of Novel Therapeutics and BiomarkersNCT07652151 · lead sponsor · 2026-01-20

Persistence of Biological Treatment and Inhibitors of Jak Kinases in Patients With Rheumatoid Arthritis.NCT05062421 · lead sponsor · 2021-04-01

Comparison of Esketamine Nasal Spray vs.Aripiprazole in Treat.Resistant Major Depressive Disorder in Elderly PatientsNCT07153406 · lead sponsor · 2025-09-15

NOT_YET_RECRUITING

EMRESERVA to Enhance Cognitive Reserve in Multiple SclerosisNCT05546424 · lead sponsor · 2022-05-19

Cognitive Effects of Adjuvant Vortioxetine in Early SchizophreniaNCT04895488 · lead sponsor · 2022-01-20

Registry of Patients with Suspected Amyloidosis in Heart FailureNCT05176548 · lead sponsor · 2022-01-15

Ambispective Cohort Study to Evaluate the Efficacy, Safety, and Tolerance of an Antiretroviral Regimen With DoravirineNCT05140603 · lead sponsor · 2021-12-01

NASH Patient's Itinerary: Comparison of Strategies for Screening, Referring and Management of Diabetic PatientsNCT06688149 · lead sponsor · 2021-01-31

Study to Compare Clozapine vs Treatment as Usual in People With Intellectual Disability & Treatment-resistant PsychosisNCT04529226 · lead sponsor · 2020-11-26

Patients With Severe Eosinophilic Asthma Treated With BenralizumabNCT05078281 · lead sponsor · 2020-11-01

Clozapine Use Pattern in the Province of SevilleNCT05083377 · lead sponsor · 2020-09-08

Prevalence of Amyloidosis in Heart Failure (PREVAMIC)NCT04066452 · lead sponsor · 2020-02-03

Safety and Efficacy of Melatonin in Patients With Multiple Progressive Primary SclerosisNCT03540485 · lead sponsor · 2019-11-29

Screening for Cancer in Patients With Unprovoked VTENCT03937583 · lead sponsor · 2019-10-23

Changes in the T-wave Alternans in Patients With Heart Failure Treated Wih Sacubitril-ValsartanNCT04185103 · lead sponsor · 2019-10-15

Accelerated Partial Irradiation of the Breast: New Altered FractionationNCT04101656 · lead sponsor · 2019-10-15

Usefulness of the Chronic Obstructive Pulmonary Disease-population (COPD-PS) Questionnaire and the COPD-6 Device in the Chronic Obstructive Pulmonary Disease Detection in a Tobacco Detoxication ConsultationNCT04121117 · lead sponsor · 2019-10-15

Prospective Observational Study of the Sacubitril-Valsartan Treatment Effectiveness.NCT04133428 · lead sponsor · 2019-04-04

Study of Real-world Evidence With SGLT2i (Dapagliflozin) and DPP4i (Sitagliptin) in Type 2 Diabetes Patients in SpainNCT04149067 · lead sponsor · 2017-06-05

So-Lo-Mo Intervention Applied to the Smoking Cessation ProcessNCT03553173 · lead sponsor · 2016-10-24

Pharmacokinetic Food-effect Study of Abiraterone Acetate (AA) in Castration Resistant Prostate CancerNCT02730975 · lead sponsor · 2014-05-12

Randomized CT to Evaluate Efficacy of Neoadjuvant Chemotherapy Customized by Levels of BRCA1-HER2 Negative Breast CancerNCT02365805 · lead sponsor · 2014-04-01

VERifynow in DIabetes Non-responsiveness: a Study on Switching From Clopidogrel to PrasugrelNCT01684813 · lead sponsor · 2012-10-01

Time-based Register and Analysis of COPD EndpointsNCT03485690 · lead sponsor · 2012-01-01

Study for Asthma Education in Primary SchoolsNCT01607749 · lead sponsor · 2011-11-01

ELECTROVEST: Electro-Stimulation Vibratory Vest for Pulmonary Rehabilitation in Patients With Chronic Respiratory DiseasesNCT07175012 · collaborator · 2023-10-02

Effectiveness of an Exercise Program and Education Through a Mobile Application for the Management of Patients With Hand Osteoarthritis and Rheumatoid ArthritisNCT04263974 · collaborator · 2020-03-01

Vedolizumab Treatment in HIV-Infected Subjects Without Previous Antiretroviral TherapyNCT03577782 · collaborator · 2018-09-01

Atrial Fibrillation Research In CATaloniaNCT03188484 · collaborator · 2016-05-01

Spanish Atrial Fibrillation And Resynchronization StudyNCT01181414 · collaborator · 2010-10-01

Drugs studied in this sponsor's trials

7 mapped RxNorm concepts

These drug records are connected through ClinicalTrials.gov studies listing Fundación Pública Andaluza para la gestión de la Investigación en Sevilla as a sponsor, collaborator or responsible party. Each count is the number of distinct trials containing the mapped drug intervention. This does not establish that the organization manufactures, owns, sells or developed the drug.

Most studied mapped drug conceptsDistinct linked trials per RxNorm concept; one trial may study several drugs.

sacubitril / valsartan2

clopidogrel1

clozapine1

dapagliflozin1

melatonin1

sitagliptin1

vortioxetine1

sacubitril / valsartan RxCUI 1656339 · Lead sponsor in 2 linked trial(s) · 0 currently recruiting 2 trials clopidogrel RxCUI 32968 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial clozapine RxCUI 2626 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial dapagliflozin RxCUI 1488564 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial melatonin RxCUI 6711 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial sitagliptin RxCUI 593411 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial vortioxetine RxCUI 1455099 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial

Sponsor roles

lead sponsor25

collaborator5

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.